Microbot Medical Stock Profit Margin
CY9D Stock | EUR 0.93 0.04 4.12% |
Microbot Medical fundamentals help investors to digest information that contributes to Microbot Medical's financial success or failures. It also enables traders to predict the movement of Microbot Stock. The fundamental analysis module provides a way to measure Microbot Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Microbot Medical stock.
Microbot |
Microbot Medical Company Profit Margin Analysis
Microbot Medical's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition |
Based on the latest financial disclosure, Microbot Medical has a Profit Margin of 0.0%. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Instruments & Supplies industry. The profit margin for all Germany stocks is 100.0% lower than that of the firm.
Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
All Next | Launch Module |
Microbot Fundamentals
Return On Equity | -1.2 | |||
Return On Asset | -0.65 | |||
Current Valuation | 25.69 M | |||
Shares Outstanding | 7.89 M | |||
Shares Owned By Insiders | 3.07 % | |||
Shares Owned By Institutions | 29.65 % | |||
Price To Book | 5.90 X | |||
EBITDA | (11.28 M) | |||
Net Income | (11.31 M) | |||
Cash And Equivalents | 20.62 M | |||
Cash Per Share | 2.90 X | |||
Total Debt | 708 K | |||
Debt To Equity | 0.04 % | |||
Current Ratio | 17.41 X | |||
Book Value Per Share | 0.78 X | |||
Cash Flow From Operations | (9.35 M) | |||
Earnings Per Share | (1.76) X | |||
Number Of Employees | 20 | |||
Beta | 3.26 | |||
Market Capitalization | 20.07 M | |||
Total Asset | 16.77 M | |||
Z Score | 16.8 | |||
Net Asset | 16.77 M |
About Microbot Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Microbot Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Microbot Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Microbot Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Microbot Stock
When determining whether Microbot Medical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Microbot Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Microbot Medical Stock. Highlighted below are key reports to facilitate an investment decision about Microbot Medical Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more detail on how to invest in Microbot Stock please use our How to Invest in Microbot Medical guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.